Driving AI Adoption in Pathology Across Europe – Highlights from the 11th Congress

Singapore, December 17, 2024 — Qritive participated in the 11th Digital Pathology & AI Congress: Europe, held on 11–12 December 2024 in London, where our team showcased how AI-driven solutions are shaping the future of diagnostics.

The congress brought together leading voices in digital pathology and artificial intelligence, highlighting the rapid progress in the adoption of digital workflows across Europe. Discussions throughout the event emphasized the growing recognition of AI as a critical enabler in improving diagnostic accuracy and operational efficiency within pathology services.

Our team had the opportunity to share Qritive’s advancements in digital pathology and engage in meaningful conversations with industry stakeholders on the evolving landscape of AI integration in clinical settings.

We extend our thanks to the organizers for hosting a well-curated and insightful event that continues to push the boundaries of innovation in digital diagnostics.

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com.